SS&C Technologies Holdings Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SS&C Technologies Holdings Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $438.37M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $418.25M | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $410.98M | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $407.70M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $400.92M | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $383.30M | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $373.08M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $324.13M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $300.89M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $280.89M | Feb 28, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.27B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.88B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.50B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.28B | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $5.05B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $4.67B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $1.20B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $1.14B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $1.15B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $1.14B | Feb 28, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $300.89M | Feb 29, 2016 |
| FY2015 | Sep 30, 2015 | $280.89M | Feb 29, 2016 |
| FY2015 | Jun 30, 2015 | $212.77M | Feb 29, 2016 |
| FY2015 | Mar 31, 2015 | $205.74M | Feb 29, 2016 |
| FY2015 | Dec 31, 2014 | $200.73M | Feb 29, 2016 |
| FY2015 | Sep 30, 2014 | $192.60M | Feb 29, 2016 |
| FY2015 | Jun 30, 2014 | $188.72M | Feb 29, 2016 |
| FY2015 | Mar 31, 2014 | $185.81M | Feb 29, 2016 |
| FY2014 | Dec 31, 2013 | $182.52M | Feb 26, 2015 |
| FY2014 | Sep 30, 2013 | $179.51M | Feb 26, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.02B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.86B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.65B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.52B | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $2.41B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.09B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $545.50M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $501.50M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $498.90M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $475.30M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $796.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $760.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $607.10M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $650.20M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $800.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $625.20M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $141.60M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $95.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $121.10M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $80.80M | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.21B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.14B | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $1.24B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $985.80M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $261.30M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $227.60M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $223.50M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $202.00M | Feb 28, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $507.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $517.70M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $473.80M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $447.30M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $414.90M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $399.40M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $383.70M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $318.20M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $153.30M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $152.70M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.13B | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $1.43B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.18B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.33B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $640.10M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $471.80M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $418.40M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.80M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $61.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $56.60M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $63.40M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $51.30M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $34.80M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $63.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $33.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $35.50M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $27.90M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $19.04B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $18.10B | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $16.65B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $17.33B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $15.92B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $16.74B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $16.11B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $5.54B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.71B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.77B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $12.44B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $11.70B | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $10.55B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $11.11B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $10.21B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $11.63B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $11.53B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.85B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.45B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.89B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $6.53B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $6.34B | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $6.04B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $6.17B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.72B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $5.12B | Feb 25, 2021 |
| FY2020 | Dec 31, 2018 | $4.58B | Feb 25, 2021 |
| FY2020 | Dec 31, 2017 | $2.69B | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $2.26B | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.99B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $9.22B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $8.97B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $8.86B | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $8.05B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $8.08B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $7.96B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $7.86B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $3.71B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $3.65B | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.18B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.64B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.13B | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $2.74B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.29B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.67B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.18B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $847.10M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $766.90M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $492.35M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $462.10M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $567.10M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $432.20M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $440.10M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $564.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $209.30M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $152.80M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $166.70M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $64.10M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $117.60M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $782.00M | Feb 27, 2014 |
| FY2012 | Dec 31, 2012 | $1.02B | Mar 1, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 241.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 244.50M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 246.60M | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | 251.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 256.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 257.60M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 254.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 250.80M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 206.50M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 203.04M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.80M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $244.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $220.90M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $203.10M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $174.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $136.10M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $107.70M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $70.90M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $54.40M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $50.10M | Mar 1, 2019 |